Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A

American Journal of Veterinary Research

Volumn 59, Issue 5, 1998, Pages 603-608

  Muir III, William W ^a   Gadawski, Jennifer ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEVOFLURANE;

ANESTHESIOLOGICAL TECHNIQUES; ANESTHETIC EQUIPMENT; ANIMAL EXPERIMENT; ARTICLE; BREATHING RATE; DOG; HEART RATE; INHALATION ANESTHESIA; NONHUMAN;

EID: 0031806491     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.1998.59.5.603     Document Type: Article

References (33)

1. Mutoh T, Nishimura R, Kim HY, et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 1997;58:885-890.
2. Ebert T, Harkin C, Muzi M. Cardiovascular response to sevoflurane: a review. Anesth Analg 1995;81:S11-S22.
3. Imamura S, Ikeda K. Comparison of the epinephrine-induced arrhythmogenic effect of sevoflurane with isoflurane and halothane. J Anesth 1987;1:62-68.
4. Green W Jr. The ventilatory effects of sevoflurane. Anesth Analg 1995;81:S23-S26.
5. Kharasch E, Karol M, Lanni C, et al. Clinical sevoflurane metabolism and disposition (I). Anesthesiology 1995;82:1369-1378.
6. Kharasch E, Armstrong A, Gunn K, et al. Clinical sevoflurane metabolism and disposition (II). Anesthesiology 1995;82:1379-1388.
7. Goldberg M, Cantillo J, Ghassem L, et al. Sevoflurane versus isoflurane for maintenance of anesthesia: are serum inorganic fluoride ion concentrations of concern? Anesth Analg 1996;82:1268-1272.
8. 2 absorbents during low-flow anesthesia in surgical patients. Anesthesiology 1992;77:1064-1069.
9. Fang Z, Eger E II. Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and Baralyme in a standard anesthetic circuit. Anesth Analg 1995;81:564-568.
10. Fang E, Kandel L, Laster MJ, et al. Factors affecting production of compound A from the interaction sevoflurane with Baralyme and soda lime. Anesth Analg 1996;82:775-781.
11. Cunningham DD, Huang S, Webster J, et al. Sevoflurane degradation to compound A in anaesthesia breathing. Br J Anaesth 1996;77:535-543.
12. Eger E II, Laster M, Winegar R, et al. Compound A induces sister chromatid exchanges in Chinese hamster ovary cells. Anesthesiology 1997;86:918-922.
13. Mazze R, Jamison R. Low-flow (1 1/min) sevoflurane. Anesthesiology 1997;86:1225-1227.
14. Bednarski RM, Bednarski LS, Muir WW III. Cost comparison of anesthetic regimens in the dog and cat. J Am Vet Med Assoc 1984;185:869-872.
15. Bednarski RM, Muir WW III. Closed system delivery of halothane and isoflurane with a vaporizer in the anesthetic circle. Vet Surg 1991;20:353-356.
16. Bednarski RM, Gaynor JS, Muir WW III. Vaporizer in circle for delivery of isoflurane to dogs. J Am Vet Med Assoc 1993;202:943-948.
17. Wagner AE, Bednarski RM Use of low-flow and closed-system anesthesia. J Am Vet Med Assoc 1992;200:1005-1010.
18. Frink E Jr, Green W Jr, Brown E, et al. Compound A concentrations during sevoflurane anesthesia in children. Anesthesiology 1996;84:566-571.
19. Lin C-Y. Assessment of vaporizer performance in low-flow and closed-circuit anesthesia. Anesth Analg 1980;59:359-366.
20. Morio M, Fujii K, Satoh N, et al. Reaction of sevoflurane and its degradation products with soda lime. Anesthesiology 1992; 77:1155-1164.
21. Gonsowski CT, Laster MJ, Eger E II, et al. Toxicity of compound A in rats: Effects of a 3-hour administration. Anesthesiology 1994;80:556-565.
22. Gonsowski CT, Laster MJ, Eger E II, et al. Toxicity of compound A in rats: effect of increasing duration of administration. Anesthesiology 1994;80:566-573.
23. Smith I, Nathanson M, White PF. Sevoflurane-a long-awaited volatile anaesthetic. Br J Anesth 1996;76:435-445.
24. Mushin WW, Galloon WW. The concentration of anesthetics in closed circuits with special reference to halothane III. Clinical aspects. Br J Anaesth 1960;32:324-333.
25. Harkin C, Pagel P, Kersten J, et al. Direct negative inotropic and lusitropic effects of sevoflurane. Anesthesiology 1994;81:156-167.
26. Hatakeyama N, Momose Y, Ito Y. Effects of sevoflurane on contractile responses and electrophysiologic properties in canine single cardiac myocytes. Anesthesiology 1995;82:559-565.
27. Hirano M, Fujigaki T, Shibata O, et al. A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg 1995;80:651-656.
28. Rodig G, Keyl C, Wiesner G, et al. Effects of sevoflurane and isoflurane on systemic vascular resistance: use of cardiopulmonary bypass as a study model. Br J Anaesth 1996;76:9-12.
29. Eger E II. New inhaled anesthetics. Anesthesiology 1994;80: 906-922.
30. Ide T, Kochi T, Isono S, et al. Different effects of halothane and enflurane on diaphragmatic contractility in vivo. Anesth Analg 1990;70:362-368.
31. Levine MF, Sarner J, Lermen J, et al. Plasma inorganic fluoride concentrations after sevoflurane anesthesia in children. Anesthesiology 1996;84:348-353.
32. Kandel L, Laster MJ, Eger E II, et al. Nephrotoxicity in rats undergoing a one-hour exposure to compound A. Anesth Analg 1995;81:559-563.
33. Kharasch E, Frink E, Zagar R, et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997;86:1238-1253.